Antimicrobial and Antibacterial Agents

Transcription

1 International Conference on Antimicrobial and Antibacterial Agents Novembe19-20, 2018 Bucharest, Romania T E N T A T I V E P R O G R A M Conferences Series llc LTD 47 Churchfield Road London W3 6AY, UK Antimicrobial Congress 2018

2 EVENT PROGRAM November 19, 2018 Opening Ceremony 08:30-09:00 Keynote Sessions 09:00-10:30 Panel Discussion 10:30-10:40 Antimicrobial Agents in Clinical Treatment 11:00-13:00 Lunch Break 13:00-14:00 Antimicrobial Pathogens : Alternative Approaches, Antimicrobial agents and novel 14:00-16:00 vaccines Workshop 16:00-18:00 Note: Event Program is subjected to change with final allotment of Speaker slots

3 EVENT PROGRAM November 20, 2018 Keynote Sessions 09:00-10:30 Community acquired antimicrobial resistance: 11:00-13:00 is it controllable?, Plant Based Vaccines, Antimicrobial therapy for gum disease Haematology & Immune System Diseases Lunch Break 13:00-14:00 Plant Based Vaccines, Pediatric Infectious Disease`, Antibiotic resistance leads to increased 14:00-15:30 mortality Poster Presentations 16:00-17:00 Poster and Video Presentation 17:00-18:00 Note: Event Program is subjected to change with final allotment of Speaker slots

4 SCIENTIFIC SESSIONS Antimicrobial agents and novel vaccines Antimicrobial Pathogens: Alternative Approaches Antibiotic Therapy & Antimicrobial Drugs Antimicrobial Agents & Chemotherapy Antimicrobial Agents in Clinical Treatment Pharmalogical Consideration of Infectious Disease and Agents Global Antibacterial Drugs Market Key Antimicrobial Textiles Market Neuroinfectious Diseases Molecular Epidemiology of Neoplastic and Non-neoplastic disease Plant Based Vaccines Antimicrobiology in Epidemiology Antimicrobial therapy for gum disease Pediatric Infectious Disease Antibiotic resistance leads to increased mortality Infection Diseases and Agents Community acquired antimicrobial resistance: is it controllable?

5 Antimicrobial Congress 2018 TENTATIVE PROGRAM Organizing Committee Member Pietro Mastroeni SESSION TALKS Pietro Mastroeni received a Degree in Medicine and Surgery from the University of Messina, Italy. He moved to the University of Cambridge, UK where he completed his PhD before becoming a Research Fellow at Imperial College, University of London UK. He is currently a Reader in Infection and Immunity at the University of Cambridge, UK. In 2017 he was awarded the Higher Degree of Doctor of Science (ScD) st Cambridge and he is a Fellow of the Royal Society of Biology. He has published more than 120 papers in reputed journals, edited two books and he serves as an editorial board member for several international journals. Title:Why do bacteria persist beyond antibiotic treatment? Peiro Mastroni, University of Cambridge, United Kingdom Title: Engdevelopment Of Bio-Based Polymers Based On Agroforestry Waste Extractions Of Lignins Cured And Reinforced With Antimicrobial Agents Delaying Fungal And Bacterial Activity By Increasing The Period Of Life Of A Food On The Shelf Luis Eduardo, Mexico Title: High-level aminoglycoside resistance in the absence of 16S ribosomal RNA methyltransferase production among Gram-negative bacilli Darini Ana Lucia, Brazil Title: Flu Pathogenesis Proteolytic Theory And Its Role In The Improvement of Flu s Treatment Valentina Divocha, Lugansk State Medical University, Rubezhnoe, Ukraine Title:Microbiological and Physico-chemical Screening of Indian Honey Padma Singh, Department of Microbiology, Gurukul Kangri University, India Title: SCCmec and meca in methicillin resistant staphylococci, a highly diversified element with new mutations in meca Ferhat DJOUDI, Algeria Title: Persister phenotype diversity in P. aeruginosa populations from airways of patients with cystic fibrosis Biljana Mojsoska, Denmark Title: probability inspection using solution and ozone gas for lichen removal in historical levels for case study of perspolice pilot Hossein Naderi, Iran Title:Role of bacterial antioxidant defense in their resistance to bactericidal antibiotics A C Matin, Professor of Microbiology and Immunology, Stanford University School of Medicine

6 Antimicrobial Congress 2018 TENTATIVE PROGRAM Organizing Committee Member Pierre A Morgon SESSION TALKS Pierre A Morgon is CEO of MRGN Advisors and Regional Partner for Switzerland at Mérieux Développement. He is Chairman of the Board of Virometix, as well as Non-Executive Director to the Boards of Theradiag, of Eurocine Vaccines, and of Vaccitech. Pierre has over 30 years of experience in the global life science industry, especially with specialty care, vaccines and immunotherapy, at the helm of international operations, in C-level positions at global level in multinational corporations and as CEO of start-up companies. He is a lecturer in several MBA programs in world-class business schools and in life science conferences, and at the Mass Challenge biotechnology incubator in Switzerland. Title: Community-Acquired Methicillin-Resistant Staphylococcus aureus: characteristics epidemiology, clinical, microbiology and molecular biology ; SCCmec gene analysis and VISA in patients infected with Staphylococcus aureus and antibiotic resistance testing in 2 hospitals. Latre Buntaran, Head of Microbiology Department Mayapada Hospitals, Indonesia Title: Influence of sub-bactericidal concentrations of antiseptics on DNA and phenotypic markers of virulence of microorganisms Anna G Afinogenova, St. Petersburg Pasteur Institute, Russia Title: Let s quench the quorum; a novel approach to counter Quorum Sensing mechanism in the pathogenic Pseudomonas aeruginosa Fazal Adnan, Pakistan Title: Commonly use of Oral Antibiotics Resistance in Children Aged 1 to 12 Years with UTIs a Increasing Problem Biswajit Batabyal, Research Scholar, OPJS University Churu, Rajasthan, India Title: Panton valentine leukocidin (Luks PVL) producing methicillin resistant Staphylococcus aureus from health care centers in Tabuk City, Kingdom of Saudi Arabia Bernard C Silvala, University of Tabuk, Tabuk City, Kingdom of Saudi Arabia

7 Contact: Francis Bennett Tel: ; Ext: Venue Bucharest, Romania